Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol
2024 · BMJ Open · 6 citations
https://doi.org/10.1136/bmjopen-2024-088862
R
Ryuta Shigefuku
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
519
Citations
12
h-index
21
i10-index
Ryuta Shigefuku is an academic researcher from Shibaura Institute of Technology. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Hepatitis C virus research. The author has an h-index of 12, co-authored 57 publications.
ORCID: 0000-0002-6738-4382Papers by this author
worksRecurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report
2022 · Journal of Medical Case Reports · 4 citations
https://doi.org/10.1186/s13256-022-03355-1
Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function
2022 · BMC Gastroenterology · 4 citations
https://doi.org/10.1186/s12876-022-02422-7
Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and rats
2025 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-025-17560-7
Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics
2025 · Anticancer Research · 0 citations
https://doi.org/10.21873/anticanres.17432
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat